China's Draft Cell Therapy Guidelines Draws Concern From Industry

 
• By Brian Yang
  
CHINA CDE'S SENIOR REVIEWER HUANG HONGYUN AT CHINA RARE DISEASE SUMMIT LAST SEPTEMBER • Source: The Pink Sheet
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from China

More from Asia